Literature DB >> 27754864

Markers of Vascular Dysfunction After Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis.

Sophie Grand'Maison1, Louise Pilote1, Marisa Okano1, Tara Landry1, Natalie Dayan2.   

Abstract

Women with prior hypertensive disorders of pregnancy (HDP) are at twice the risk of cardiovascular disease compared with women with prior normotensive pregnancy, possibly because of sustained vascular dysfunction after delivery. The aim of this systematic review and meta-analysis is to summarize evidence of vascular dysfunction at least 3 months after HDP. Articles in all languages were retrieved from principal databases. Studies included were observational, with HDP as the main exposure and measurements of vascular dysfunction via imaging modalities or serum biomarkers as the main outcome, assessed at least 3 months postpartum. We pooled results of modalities reported in >3 studies using a random effects model. Of 6109 potentially relevant studies, 72 were included that evaluated 10 imaging modalities and 11 serum biomarkers in 8702 women. There was evidence of vascular dysfunction in women post HDP compared with women with prior normal pregnancy when measured by carotid-femoral pulse wave velocity (0.64 m/s [0.17-1.11]), carotid intima-media thickness (0.025 mm [0.004-0.045]), and augmentation index (5.48% [1.58-9.37]), as well as mean levels of soluble fms-like tyrosine kinase (6.12 pg/mL [1.91-10.33]). Between-groups differences in measures of vascular dysfunction were more pronounced when assessments were performed in younger women (<40 years) or closer to the index pregnancy for almost all modalities. In conclusion, pooled data from studies evaluating vascular imaging suggest that some vascular dysfunction persists after HDP as compared with women with prior normal pregnancy.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  biomarkers; endothelium; hypertension; imaging; preeclampsia/pregnancy; pregnancy and postpartum

Mesh:

Substances:

Year:  2016        PMID: 27754864     DOI: 10.1161/HYPERTENSIONAHA.116.07907

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

Review 1.  Anti-angiogenesis and Preeclampsia in 2016.

Authors:  Susanne Schrey-Petersen; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

Review 2.  Residual vascular dysfunction in women with a history of preeclampsia.

Authors:  Anna E Stanhewicz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-22       Impact factor: 3.619

Review 3.  Vascular Dysfunction in Mother and Offspring During Preeclampsia: Contributions from Latin-American Countries.

Authors:  Fernanda Regina Giachini; Carlos Galaviz-Hernandez; Alicia E Damiano; Marta Viana; Angela Cadavid; Patricia Asturizaga; Enrique Teran; Sonia Clapes; Martin Alcala; Julio Bueno; María Calderón-Domínguez; María P Ramos; Victor Vitorino Lima; Martha Sosa-Macias; Nora Martinez; James M Roberts; Carlos Escudero
Journal:  Curr Hypertens Rep       Date:  2017-10-06       Impact factor: 5.369

4.  Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Lacy M Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

5.  Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy.

Authors:  Michael C Honigberg; Seyedeh Maryam Zekavat; Krishna Aragam; Derek Klarin; Deepak L Bhatt; Nandita S Scott; Gina M Peloso; Pradeep Natarajan
Journal:  J Am Coll Cardiol       Date:  2019-11-11       Impact factor: 24.094

Review 6.  Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women.

Authors:  Anna C O'Kelly; Erin D Michos; Chrisandra L Shufelt; Jane V Vermunt; Margo B Minissian; Odayme Quesada; Graeme N Smith; Janet W Rich-Edwards; Vesna D Garovic; Samar R El Khoudary; Michael C Honigberg
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

7.  Acute systemic inhibition of inflammation augments endothelium-dependent dilation in women with a history of preeclamptic pregnancy.

Authors:  Anna E Stanhewicz; Gabrielle A Dillon; Corinna Serviente; Lacy M Alexander
Journal:  Pregnancy Hypertens       Date:  2021-12-28       Impact factor: 2.899

8.  The Association of Adverse Pregnancy Outcomes and Cardiovascular Disease: Current Knowledge and Future Directions.

Authors:  Anum S Minhas; Wendy Ying; S Michelle Ogunwole; Michael Miller; Sammy Zakaria; Arthur J Vaught; Allison G Hays; Andreea A Creanga; Ari Cedars; Erin D Michos; Roger S Blumenthal; Garima Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-10-31

9.  Circulating miR-206 and Wnt-signaling are associated with cardiovascular complications and a history of preeclampsia in women.

Authors:  Kenny Schlosser; Amanpreet Kaur; Natalie Dayan; Duncan J Stewart; Louise Pilote; Christian Delles
Journal:  Clin Sci (Lond)       Date:  2020-01-31       Impact factor: 6.124

10.  Pre-pregnancy endothelial dysfunction and birth outcomes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Abbi D Lane-Cordova; Erica P Gunderson; Mercedes R Carnethon; Janet M Catov; Alex P Reiner; Cora E Lewis; Annie M Dude; Philip Greenland; David R Jacobs
Journal:  Hypertens Res       Date:  2018-02-15       Impact factor: 5.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.